5 Best Closed-End Funds for 2026 | Investing

Exchange-traded funds, or ETFs, are popular these days, but closed-end funds, or CEFs, can be a great option for investors seeking income as well.

The April 29 initial public offering of closed-end fund Pershing Square USA Ltd. (ticker: PSUS), run by billionaire investor Bill Ackman, put a spotlight on CEFs as one of the largest such IPOs in history. PSUS debuted as a key component of a combined IPO of Ackman’s alternative asset management firm. Pershing Square Inc. is also trading under the ticker PS on the New York Stock Exchange, and PSUS IPO investors got shares of PS as an incentive. Pershing raised $5 billion ⁠(granted, at the low end of expectations) for ⁠the new closed-end fund, its first fund with no performance fees marketed to both U.S. ⁠institutional and ⁠retail investors.

Closed-end funds, or CEFs, have portfolios with dividends and capital gains distributions, but they are different from ETFs because they are unable to create new shares or redeem them on a day-to-day basis. A CEF enters the market with a fixed amount of shares via an IPO. CEF shares can track a variety of underlying assets, including equities, fixed income, commodities and even cryptocurrencies. Once issued, the shares then trade on the secondary market between individual investors.

“By not rebuying the shares, closed-end funds can invest more of the assets and not have to keep low-earning cash on hand,” says Steve Azoury, a chartered financial consultant and owner of Azoury Financial. This also insulates the fund from investor flows, which is a key upside in volatile markets.

“Closed-end funds play an important role in a diversified portfolio,” says Stephen Minar, managing director and head of closed-end funds at BlackRock. “They provide consistent distributions for those looking for steady income as part of their retirement solution, and they allow individual investors to gain exposure to illiquid or otherwise inaccessible asset classes, like private markets or real estate.”

CEFs can also be great vehicles for gaining single-country exposure without single-stock risk, says Steven Conners, founder and president of Conners Wealth Management. “Single-stock exposure in a foreign country may be riskier due to a lack of analyst coverage, among other risk factors.”

He gives the example of the New Germany Fund Inc. (GF). “Germany is the strongest economy in Western Europe,” and GF gives you far more diversification than just buying a single German stock, he says.

Risk is an important consideration when investing in CEFs, and it can vary widely from fund to fund. Conners says to avoid funds with high price volatility, as this is often a sign of too much risk.

CEFs can also use leverage, which involves borrowing money to increase the fund’s upside potential. But you can’t amplify the potential upside without also amplifying the potential downside, so take care when investing in any fund that uses leverage.

These funds can also have high management fees that erode returns and use derivative strategies that increase complexity.

You’ll want to pay close attention to the size of the fund before investing. Small funds, like those that trade less than 20,000 shares per day, may make it hard to find a buyer willing to pay a fair price when you want to sell. It can also amplify the discount or premium from NAV.

When evaluating CEFs, start by asking yourself what you want the fund to do for you, Conners says. For instance, do you want to generate income or long-term capital growth? You can then screen potential funds for their ability to meet your objective and respective risk level.

The team managing the fund is also critical to consider as it will determine the success – or lack thereof – of the portfolio, Conners adds. “For example, BlackRock is a great sponsor of closed-end funds,” but you should look closely at the track record of lesser-known providers.

“Another question is, what are they known for?” Conners says. “Jeffrey Gundlach and DoubleLine are known for income funds, especially in emerging countries, whereas PIMCO is known more for income funds in the U.S.”

The closed structure of these funds means the share price of a CEF can diverge from its net asset value, or NAV, and trade at a premium or a discount depending on supply and demand. For example, the NAV may be $20 per share while the fund is trading at a discount of $18 per share, or a premium of $22 per share.

“Don’t pay a rich premium over NAV” – like a premium of over 40% – because the “risk is typically much higher,” Conners says. “Although, purchasing a fund at a discount does not insulate you from risk either.”

Taken together, these considerations can help narrow the field to funds with durable income, disciplined management and a structure that aligns with your goals. With that in mind, here are five of the best closed-end funds to buy in 2026:

BlackRock ESG Capital Allocation Term Trust (ECAT)

Starting off strong, this closed-end fund proves you can invest responsibly and profitably without taking on excessive risk.

ECAT invests in equities and debt securities, 80% of which must meet environmental, social and governance (ESG) criteria. And it does so while providing an impressive 22.1% distribution rate.

“ECAT’s diversified, risk-managed strategy provides the flexibility to invest across multiple asset classes,” Minar says.

Perhaps most impressive of all is that it manages this high distribution rate without excessive leverage. Unlike other funds on this list, ECAT has a leverage ratio of only 0.17% from writing options to generate income. This helps increase the fund’s risk-adjusted returns.

ECAT is also unique in its limited structure: The trust is scheduled to dissolve around Sept. 27, 2033, unless the Board of Trustees votes to extend its term.

“The limited term structure is valuable because it provides shareholders with the assurance that they will receive 100% liquidity at the value of the fund’s holdings at the end of the term,” Minar says. “For example, ECAT shareholders will continue to benefit from monthly distributions until the fund reaches its 12-year term in 2033, at which point they will have guaranteed liquidity at net asset value.”

As an added bonus, the fund is currently trading at around a 4.3% discount to its NAV.

PIMCO Corporate & Income Opportunity Fund (PTY)

If your goal is reliable income, this closed-end fund is hard to ignore. PTY focuses on income-producing assets like corporate bonds, mortgage-backed securities and other areas of the credit market, with the flexibility to shift allocations as conditions change. That active management approach has helped the fund deliver steady monthly income over time, even as markets move through different cycles.

The yield is one of its biggest draws, which is currently in the double digits. But that higher income comes with trade-offs. The fund uses leverage to boost returns, which can work in your favor when markets are stable, but can also amplify losses when interest rates rise or credit conditions weaken.

Another thing that sets PTY apart is its flexibility. Instead of sticking to a narrow slice of the bond market, the managers can move between investment-grade bonds and high-yield credit to find opportunities. That can be a real advantage in a shifting rate environment, but may increase risk if high-yield debt is favored.

One catch is that investors are often willing to pay a premium for that consistency. PTY has historically traded at a premium to its net asset value, which means you’ll want to keep an eye on valuation before jumping in. It’s currently priced at a 6% premium.

abrdn Healthcare Investors (HQH)

If you’re a true bargain shopper, HQH may be the fund for you. It has averaged a double-digit discount over the past three years, giving investors the opportunity to pick up its underlying holdings at a relative bargain. That discount has narrowed recently and currently sits in the mid-single digits, but it still offers a margin of safety compared to funds trading at a premium.

Income is another big part of the appeal. HQH offers a distribution rate of nearly 13%, paired with a relatively moderate expense ratio around 1.1%. Like many equity-focused CEFs, however, that payout can fluctuate over time depending on market conditions and realized gains, so it’s not quite as predictable as a bond-heavy income fund.

As the name suggests, HQH invests primarily in health care companies, with a portfolio of more than 100 holdings. These companies range from biotech and pharmaceutical firms to health care suppliers and facilities.

That focus can be a double-edged sword. Health care has long-term tailwinds, from aging populations to ongoing innovation, but it can also be volatile, especially in biotech. For investors who are comfortable with those swings, HQH offers a way to tap into the sector while collecting income and potentially buying in at a discount.

Adams Diversified Equity Fund (ADX)

If you want income but don’t love the added risk that comes with leverage, ADX is worth a closer look.

This long-running closed-end fund takes a more straightforward approach, investing primarily in large U.S. stocks and skipping leverage altogether. That can make it less volatile than many income-focused CEFs, especially those that rely on borrowed money to boost returns.

Instead of generating income through bonds or complex strategies, ADX uses a managed distribution policy, aiming to pay out at least 2% of its average net asset value in quarterly distributions. That payout typically comes from a mix of income and realized capital gains. This means distributions can vary depending on market performance, but it also gives the fund flexibility to maintain income over time.

The portfolio itself leans heavily toward blue-chip names, including familiar companies like Nvidia Corp. (NVDA), Apple Inc. (AAPL) and Microsoft Corp. (MSFT). In other words, you’re getting broad exposure to the U.S. equity market, with a tilt toward large-cap growth and dividend-paying stocks. And you’re likely getting it at a discount: ADX has historically traded at a discount to its net asset value and is currently going for nearly 4.4% under NAV.

For those looking for a simpler, equity-based CEF with a long track record, ADX offers a more conservative way to generate income without taking on too much complexity.

New Germany Fund Inc. (GF)

If you’re looking to diversify beyond U.S. markets without picking individual foreign stocks, this fund offers a straightforward way in.

GF focuses on German equities, giving investors exposure to one of Europe’s largest and most established economies. Instead of betting on a single company, you’re getting a basket of firms across sectors like industrials, tech and materials. This helps spread out company-specific risk. And that diversification can be especially useful in international markets, where individual stocks may have less analyst coverage or be harder for U.S. investors to evaluate.

GF has historically traded at a double-digit discount to its net asset value and now sits at a discount of just under 9%. While its distribution rate isn’t as high as others on this list, the extra income is a valuable addition to international diversification.

For investors who want to expand their portfolio globally while still keeping things relatively simple, GF provides a way to gain targeted exposure to a major developed market without having to pick winners on your own.